Article Text
PDFPerspectives
Head-injury-induced pituitary dysfunction. An old curiosity rediscovered
Statistics from Altmetric.com
Footnotes
Competing interests: Dr Carlo Acerini has received research funding, honoraria for speaking at meetings or has served on advisory board panels on behalf of the following pharmaceutical companies who manufacture and sell recombinant human growth hormone: Novo-Nordisk, Pfizer, Ferring.
This Perspective comments on a paper that was published in the February 2008 issue of Archives of Disease in Childhood.13
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
2008 BMJ Publishing Group and Royal College of Paediatrics and Child Health